Paper36973407
Nucleotide metabolism: a pan-cancer metabolic dependency.
Mullen NJ and 1 other. Nat Rev Cancer, 2023. Cited by 389 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Nucleotide metabolism: a pan-cancer metabolic dependency. Papers, record 36973407. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36973407
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Humans | |
| Nucleotides | |
| Energy Metabolism |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA216853 | NCI NIH HHS | United States | R01CA216853 | PubMed and NIH | NIH RePORTER |
| U54 CA274329 | NCI NIH HHS | United States | U54CA274329 | PubMed and NIH | NIH RePORTER |
| R01 CA163649 | NCI NIH HHS | United States | R01CA163649 | PubMed and NIH | NIH RePORTER |
| F30 CA265277 | NCI NIH HHS | United States | F30CA265277 | PubMed and NIH | NIH RePORTER |
| R01 CA210439 | NCI NIH HHS | United States | R01CA210439 | PubMed and NIH | NIH RePORTER |
| R01 CA270234 | NCI NIH HHS | United States | R01CA270234 | PubMed and NIH | NIH RePORTER |
| T32 CA009476 | NCI NIH HHS | United States | T32CA009476 | PubMed and NIH | NIH RePORTER |
References154
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19,201,187 | The molecular determinants of de novo nucleotide biosynthesis in cancer cells. | Curr Opin Genet Dev | 2009 | https://conductscience.org/library/papers/19201187 | PubMed |
| 2 | 32,103,170 | MUC1 oncoprotein mitigates ER stress via CDA-mediated reprogramming of pyrimidine metabolism. | Oncogene | 2020 | https://conductscience.org/library/papers/32103170 | PubMed |
| 3 | 26,321,679 | Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression. | Cell | 2015 | https://conductscience.org/library/papers/26321679 | PubMed |
| 4 | 1,450,049 | Multicenter phase II trial of brequinar sodium in patients with advanced melanoma. | Ann Oncol | 1992 | https://conductscience.org/library/papers/1450049 | PubMed |
| 5 | 3,122,764 | Direct experimental evidence for competitive inhibition of dihydrofolate reductase by methotrexate. | Biochem Pharmacol | 1988 | https://conductscience.org/library/papers/3122764 | PubMed |
| 6 | 2,369,734 | Phase I and pharmacokinetic study of brequinar sodium (NSC 368390). | Cancer Res | 1990 | https://conductscience.org/library/papers/2369734 | PubMed |
| 7 | 33,670,894 | The Synergism between DHODH Inhibitors and Dipyridamole Leads to Metabolic Lethality in Acute Myeloid Leukemia. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33670894 | PubMed |
| 8 | 7,481,842 | Gemcitabine: metabolism, mechanisms of action, and self-potentiation. | Semin Oncol | 1995 | https://conductscience.org/library/papers/7481842 | PubMed |
| 9 | 33,152,323 | Functional Genomics Identifies Metabolic Vulnerabilities in Pancreatic Cancer. | Cell Metab | 2021 | https://conductscience.org/library/papers/33152323 | PubMed |
| 10 | 32,732,914 | Purine metabolism regulates DNA repair and therapy resistance in glioblastoma. | Nat Commun | 2020 | https://conductscience.org/library/papers/32732914 | PubMed |
| 11 | 18,559,975 | Adenosine receptors in regulation of dendritic cell differentiation and function. | Blood | 2008 | https://conductscience.org/library/papers/18559975 | PubMed |
| 12 | 15,117,425 | Pharmacology and mechanism of action of pemetrexed. | Clin Lung Cancer | 2004 | https://conductscience.org/library/papers/15117425 | PubMed |
| 13 | 20,008,099 | Quantitation of cellular deoxynucleoside triphosphates. | Nucleic Acids Res | 2010 | https://conductscience.org/library/papers/20008099 | PubMed |
| 14 | 23,946,423 | Deoxynucleoside triphosphate (dNTP) synthesis and destruction regulate the replication of both cell and virus genomes. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/23946423 | PubMed |
| 15 | 30,470,748 | Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis. | Nat Commun | 2018 | https://conductscience.org/library/papers/30470748 | PubMed |
| 16 | 33,791,337 | The TRAIL in the Treatment of Human Cancer: An Update on Clinical Trials. | Front Mol Biosci | 2021 | https://conductscience.org/library/papers/33791337 | PubMed |
| 17 | 35,358,851 | MnTE-2-PyP protects fibroblast mitochondria from hyperglycemia and radiation exposure. | Redox Biol | 2022 | https://conductscience.org/library/papers/35358851 | PubMed |
| 18 | 30,929,914 | Suppression of oncogenic protein translation via targeting eukaryotic translation initiation factor 4E overcomes chemo-resistance in nasopharyngeal carcinoma. | Biochem Biophys Res Commun | 2019 | https://conductscience.org/library/papers/30929914 | PubMed |
| 19 | 28,255,082 | PTEN Regulates Glutamine Flux to Pyrimidine Synthesis and Sensitivity to Dihydroorotate Dehydrogenase Inhibition. | Cancer Discov | 2017 | https://conductscience.org/library/papers/28255082 | PubMed |
| 20 | 26,921,499 | ATR-CHK1-E2F3 signaling transactivates human ribonucleotide reductase small subunit M2 for DNA repair induced by the chemical carcinogen MNNG. | Biochim Biophys Acta | 2016 | https://conductscience.org/library/papers/26921499 | PubMed |
Cited by307
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 389 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,989,185 | Integrative bioinformatics and preliminary experimental validation suggest the therapeutic potential of lycorine in uterine corpus endometrial carcinoma. | BMC Complement Med Ther | 2026 | https://conductscience.org/library/papers/42989185 | PubMed |
| 42,977,770 | Balancing de novo and salvage pathways in cellular nucleotide synthesis. | Nat Metab | 2026 | https://conductscience.org/library/papers/42977770 | PubMed |
| 42,972,208 | Integrative bioinformatics and experimental validation of the prognostic and functional relevance of XDH and ITPA in non-small cell lung cancer. | Funct Integr Genomics | 2026 | https://conductscience.org/library/papers/42972208 | PubMed |
| 42,953,799 | Metabolic State Machines and Nutritional Ecology: A New Framework for Osteosarcoma Therapy. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42953799 | PubMed |
| 42,952,924 | Gene functions determine stochastic or adaptive futile transcription in cancers through deregulated start site deployments. | Front Bioinform | 2026 | https://conductscience.org/library/papers/42952924 | PubMed |
| 42,938,156 | Development and Temporal Validation of a Three-Metabolite Cerebrospinal Fluid Model for the Diagnosis of Leptomeningeal Metastasis from Solid Tumors. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42938156 | PubMed |
| 42,918,100 | Pan-Cancer Metabolic Landscapes: A Multiomics View. | J Proteome Res | 2026 | https://conductscience.org/library/papers/42918100 | PubMed |
| 42,907,429 | Host-pathogen pyrimidine metabolism drives cystic fibrosis lung disease. | Nat Commun | 2026 | https://conductscience.org/library/papers/42907429 | PubMed |
| 42,875,447 | Multi-omics profiling identifies triciribine as a biomarker-guided antimetabolite therapy for acute lymphoblastic leukemia. | NPJ Precis Oncol | 2026 | https://conductscience.org/library/papers/42875447 | PubMed |
| 42,871,157 | Nucleotide Metabolic Reprogramming in Sepsis: From Immune-Cell Fate to Organ Injury and Precision Therapeutics. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42871157 | PubMed |
| 42,860,598 | Multi-Omics Integration Reveals Metabolic Reprogramming and EMT-Driven Metastasis in Triple-Negative Breast Cancer. | Cancer Sci | 2026 | https://conductscience.org/library/papers/42860598 | PubMed |
| 42,835,604 | Integrative proteomic and metabolomic analysis reveals that ouabain inhibits DLBCL proliferation by reprogramming arginine-driven metabolic networks. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42835604 | PubMed |
| 42,829,577 | Identification of a Novel Subtype-Derived Prognostic Signature Based on Nucleotide Metabolism-Related Molecular Classification for Predicting Lung Adenocarcinoma Prognosis. | Int J Genomics | 2026 | https://conductscience.org/library/papers/42829577 | PubMed |
| 42,824,134 | Glutamine metabolism and its roles in tumor radiotherapy by regulating DNA damage repair. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42824134 | PubMed |
| 42,803,752 | Mitochondrial Metabolic Reprogramming in Glioma: Mechanisms of Tumorigenesis and Implications for Clinical Therapy. | CNS Neurosci Ther | 2026 | https://conductscience.org/library/papers/42803752 | PubMed |
| 42,802,236 | Metabolites and cancer metastasis. | Oncogene | 2026 | https://conductscience.org/library/papers/42802236 | PubMed |
| 42,793,129 | Bufalin-Loaded Multifunctional Nanodrugs for Cancer Therapy: Mechanisms, Delivery Strategies, and Translational Perspectives. | Biomolecules | 2026 | https://conductscience.org/library/papers/42793129 | PubMed |
| 42,779,914 | Physiological folate levels constrain nucleotide synthesis and increase dependence on nucleotide salvage. | bioRxiv | 2026 | https://conductscience.org/library/papers/42779914 | PubMed |
| 42,773,173 | Replication stress in cancer: origins, consequences and therapeutic opportunities. | Nat Rev Cancer | 2026 | https://conductscience.org/library/papers/42773173 | PubMed |
| 42,765,340 | Ribonucleotides Amplify Mitochondrial DNA-Driven cGAS-STING Activation via FdUMP-ribonucleotide Hybrid Particles to Potentiate Chemoimmunotherapy. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42765340 | PubMed |
Genes70
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36973407
GET https://conductscience.org/api/papers/v1/36973407/references?page=2